Maki, Katsuyuki
Astellas Pharma (Japan)
2 papers on CoChat
Most cited papers
- Verified
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
Ikeda, F., Wakai, Y., Matsumoto, S., Maki, K., Watabe, E., Tawara, S., Goto, T., Watanabe, Y., Matsumoto, F., & Kuwahara, S. (2000) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityAntimicrobial Peptides and Activities
Cited by 147
- Verified
Overexpression of Candida albicans CDR1,CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility
Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D. (2006) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 134
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free